A new plasma-electrochemical reactor mimics lighting to produce ammonia without a carbon footprint from nitrogen in the air ...
SEOUL--South Korea’s Green Cross Corp. has sought regulatory approval for Phase II trials of an experimental COVID-19 blood plasma treatment drug, the company said on Wednesday, sending its ...